|
Björn Sjöstrand is a member of Crucell’s management committee charged with leading the company’s vaccines business unit. He was the CEO at SBL Vaccines before it merged with Crucell in November 2006. Mr. Sjöstrand a Swedish national successfully headed the Crucell-SBL integration committee while directing the travel franchise and the Nordic sales force for the Crucell Group. He initiated and led a Management buyout of SBL Vaccin AB funded by 3i and SEB Företagsinvest. At SBL he successfully implemented a triumphant award-winning turnaround of the company from a loss-making company to a growth-focused profit-making company between 2004 and 2006. Between 1999 and 2001 he was the Vice President Operations & IT at Active Biotech where he was also a member of the Senior Management Team. Mr Sjöstrand completed a Bachelor of Science (BSc) degree in Economics and Business Administration at the University of Örebro. He also studied Financial Investment theory and Commercial law at the same university.
| 